Constellium SE
NYSE:CSTM
11.84 (USD) • At close March 11, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 7,080.476 | 7,239 | 8,120 | 6,152 | 4,883 | 5,907 | 5,686 | 5,237 | 4,743 | 5,153 | 3,666 | 3,495 | 3,610 | 3,556 |
| Cost of Revenue
| 6,175.024 | 6,529 | 7,448 | 5,488 | 4,393 | 5,305 | 5,148 | 4,698 | 4,227 | 4,703 | 3,183 | 3,024 | 3,132 | 3,239 |
| Gross Profit
| 905.451 | 710 | 672 | 664 | 490 | 602 | 538 | 539 | 516 | 450 | 483 | 471 | 478 | 317 |
| Gross Profit Ratio
| 0.128 | 0.098 | 0.083 | 0.108 | 0.1 | 0.102 | 0.095 | 0.103 | 0.109 | 0.087 | 0.132 | 0.135 | 0.132 | 0.089 |
| Reseach & Development Expenses
| 47.3 | 53 | 48 | 39 | 39 | 48 | 40 | 36 | 32 | 35 | 38 | 36 | 36 | 33 |
| General & Administrative Expenses
| 0 | 302 | 282 | 258 | 237 | 276 | 247 | 248 | 254 | 245 | 200 | 210 | 212 | 216 |
| Selling & Marketing Expenses
| 0 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 302.139 | 318 | 282 | 258 | 237 | 276 | 247 | 248 | 254 | 245 | 200 | 210 | 212 | 216 |
| Other Expenses
| 0 | 2 | -8 | 117 | -89 | -19 | 154 | 70 | -1 | -131 | 4 | -35 | -7 | -104 |
| Operating Expenses
| 349.439 | 373 | 330 | 297 | 276 | 324 | 287 | 284 | 286 | 280 | 238 | 246 | 248 | 249 |
| Operating Income
| 556.013 | 337 | 334 | 484 | 125 | 255 | 404 | 321 | 246 | -426 | 150 | 209 | 257 | -63 |
| Operating Income Ratio
| 0.951 | 0.047 | 0.041 | 0.079 | 0.026 | 0.043 | 0.071 | 0.061 | 0.052 | -0.083 | 0.041 | 0.06 | 0.071 | -0.018 |
| Total Other Income Expenses Net
| -425.697 | -141 | -131 | -167 | -159 | -173 | -182 | -289 | -202 | -158 | -59 | -74 | -27 | -141 |
| Income Before Tax
| 130.315 | 196 | 203 | 317 | -34 | 82 | 222 | 49 | 65 | -584 | 91 | 135 | 189 | -204 |
| Income Before Tax Ratio
| 0.018 | 0.027 | 0.025 | 0.052 | -0.007 | 0.014 | 0.039 | 0.009 | 0.014 | -0.113 | 0.025 | 0.039 | 0.052 | -0.057 |
| Income Tax Expense
| 72.398 | 67 | -105 | 55 | -17 | 18 | 32 | 80 | 69 | -32 | 37 | 39 | 47 | -34 |
| Net Income
| 54.057 | 125 | 301 | 257 | -17 | 59 | 188 | -31 | -4 | -554 | 51 | 98 | 132 | -179 |
| Net Income Ratio
| 0.029 | 0.017 | 0.037 | 0.042 | -0.003 | 0.01 | 0.033 | -0.006 | -0.001 | -0.108 | 0.014 | 0.028 | 0.037 | -0.05 |
| EPS
| 0.37 | 0.84 | 2.06 | 1.9 | -0.12 | 0.43 | 1.4 | -0.28 | -0.038 | -5.27 | 0.48 | 1 | 1.35 | -1.74 |
| EPS Diluted
| 0.37 | 0.84 | 2.02 | 1.82 | -0.12 | 0.41 | 1.36 | -0.28 | -0.038 | -5.25 | 0.48 | 0.99 | 1.35 | -1.74 |
| EBITDA
| 530.915 | 605 | 601 | 764 | 454 | 493 | 356 | 467 | 400 | -426 | 281 | 217 | 241 | -32 |
| EBITDA Ratio
| -0.023 | 0.084 | 0.076 | 0.122 | 0.079 | 0.088 | 0.1 | 0.089 | 0.076 | 0.048 | 0.076 | 0.064 | 0.065 | -0.009 |